Hui‐Ming Chang

2.8k total citations
49 papers, 2.1k citations indexed

About

Hui‐Ming Chang is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Hui‐Ming Chang has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Epidemiology. Recurrent topics in Hui‐Ming Chang's work include Complement system in diseases (8 papers), Trypanosoma species research and implications (8 papers) and Chemotherapy-induced cardiotoxicity and mitigation (8 papers). Hui‐Ming Chang is often cited by papers focused on Complement system in diseases (8 papers), Trypanosoma species research and implications (8 papers) and Chemotherapy-induced cardiotoxicity and mitigation (8 papers). Hui‐Ming Chang collaborates with scholars based in United States, China and Taiwan. Hui‐Ming Chang's co-authors include Edward T.H. Yeh, Tiziano M. Scarabelli, Rohit Moudgil, Tochukwu Okwuosa, Tetsu Kamitani, R DeGasperi, Eiji Sugiyama, E T Yeh, Masaharu Urakaze and Ichiro Okura and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Hui‐Ming Chang

47 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui‐Ming Chang United States 21 1.0k 531 486 362 331 49 2.1k
Aleksandar Ívetic United Kingdom 23 1.2k 1.2× 951 1.8× 391 0.8× 353 1.0× 179 0.5× 41 2.5k
Koichiro Mihara Canada 25 1.2k 1.2× 332 0.6× 321 0.7× 583 1.6× 189 0.6× 69 2.7k
Alessandra Tessitore Italy 28 1.2k 1.2× 394 0.7× 150 0.3× 424 1.2× 454 1.4× 80 2.6k
Mathias H. Konstandin Germany 28 1.1k 1.1× 401 0.8× 461 0.9× 317 0.9× 248 0.7× 64 2.3k
Antonella Naldini Italy 32 964 1.0× 584 1.1× 81 0.2× 389 1.1× 174 0.5× 97 2.7k
Junichiro Futami Japan 23 1.1k 1.0× 281 0.5× 117 0.2× 180 0.5× 451 1.4× 63 1.9k
Jonathan I. Wilde United Kingdom 23 824 0.8× 527 1.0× 133 0.3× 241 0.7× 223 0.7× 36 2.9k
Wei Sheng China 22 1.3k 1.2× 735 1.4× 575 1.2× 687 1.9× 279 0.8× 81 2.5k
Takako Hirata Japan 25 831 0.8× 1.2k 2.3× 127 0.3× 425 1.2× 107 0.3× 50 2.7k
Can G. Pham United States 16 1.4k 1.4× 438 0.8× 228 0.5× 369 1.0× 165 0.5× 19 2.4k

Countries citing papers authored by Hui‐Ming Chang

Since Specialization
Citations

This map shows the geographic impact of Hui‐Ming Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ming Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ming Chang more than expected).

Fields of papers citing papers by Hui‐Ming Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Ming Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ming Chang. The network helps show where Hui‐Ming Chang may publish in the future.

Co-authorship network of co-authors of Hui‐Ming Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Ming Chang. A scholar is included among the top collaborators of Hui‐Ming Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Ming Chang. Hui‐Ming Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeh, Edward T.H. & Hui‐Ming Chang. (2025). ANTHRACYCLINE-INDUCED CARDIOTOXICITY: MECHANISM AND PREVENTION.. PubMed. 135. 184–195. 1 indexed citations
2.
Wang, Jingxiong, Hua Zhang, Marc A. Augenreich, et al.. (2025). Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment. Journal of Neurochemistry. 169(3). e70024–e70024.
3.
4.
Li, Jieli, Hui‐Ming Chang, José Banchs, et al.. (2020). Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin. Cardio-Oncology. 6(1). 1–1. 30 indexed citations
5.
Yeh, Edward T.H., Michael S. Ewer, Javid J. Moslehi, et al.. (2019). Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology. Seminars in Oncology. 46(6). 397–402. 15 indexed citations
6.
Yang, Feng‐Ming, Yong Zuo, Wei Zhou, et al.. (2018). sNASP inhibits TLR signaling to regulate immune response in sepsis. Journal of Clinical Investigation. 128(6). 2459–2472. 21 indexed citations
7.
Chang, Hui‐Ming, Tochukwu Okwuosa, Tiziano M. Scarabelli, Rohit Moudgil, & Edward T.H. Yeh. (2017). Cardiovascular Complications of Cancer Therapy. Journal of the American College of Cardiology. 70(20). 2552–2565. 186 indexed citations
8.
Chang, Hui‐Ming, Rohit Moudgil, Tiziano M. Scarabelli, Tochukwu Okwuosa, & Edward T.H. Yeh. (2017). Cardiovascular Complications of Cancer Therapy. Journal of the American College of Cardiology. 70(20). 2536–2551. 262 indexed citations
9.
Zhao, Jun, WenChieh Chen, Zhihui Deng, et al.. (2017). Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome. PLoS ONE. 12(4). e0175519–e0175519. 12 indexed citations
10.
Yen, Hsiu‐Chuan, et al.. (2005). Levels of reactive oxygen species and primary antioxidant enzymes in WI38 versus transformed WI38 cells following bleomcyin treatment. Free Radical Biology and Medicine. 38(7). 950–959. 19 indexed citations
11.
Chang, Hui‐Ming. (2004). Pain and Its Management in Patients with Cancer. Cancer Investigation. 22(5). 799–809. 2 indexed citations
12.
13.
Chang, Hui‐Ming. (1999). CANCER PAIN MANAGEMENT. Medical Clinics of North America. 83(3). 711–736. 20 indexed citations
14.
Yeh, Edward T.H., Tetsu Kamitani, & Hui‐Ming Chang. (1994). Biosynthesis and processing of the glycosylphosphatidylinositol anchor in mammalian cells. Seminars in Immunology. 6(2). 73–80. 15 indexed citations
15.
Norris, John D., Susan Hall, Tetsu Kamitani, et al.. (1994). Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step. Blood. 83(3). 816–821. 34 indexed citations
16.
Yeh, Edward T.H. & Hui‐Ming Chang. (1992). Pathophysiology and principles of pain management in rheumatic diseases. Current Opinion in Rheumatology. 4(3). 332–336. 2 indexed citations
17.
Urakaze, Masaharu, Tetsu Kamitani, R DeGasperi, et al.. (1992). Identification of a missing link in glycosylphosphatidylinositol anchor biosynthesis in mammalian cells.. Journal of Biological Chemistry. 267(10). 6459–6462. 63 indexed citations
18.
Shaper, Nancy L., J H Shaper, Gregory Hollis, et al.. (1987). The gene for galactosyltransferase maps to mouse chromosome 4. Cytogenetic and Genome Research. 44(1). 18–21. 13 indexed citations
19.
Chang, Hui‐Ming, Ethan Dmitrovsky, Philip Hieter, et al.. (1986). Identification of three new Ig lambda-like genes in man.. The Journal of Experimental Medicine. 163(2). 425–435. 60 indexed citations
20.
Shaper, Nancy L., J H Shaper, Joseph L. Meuth, et al.. (1986). Bovine galactosyltransferase: identification of a clone by direct immunological screening of a cDNA expression library.. Proceedings of the National Academy of Sciences. 83(6). 1573–1577. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleksandar Ívetic Breakdown of academic impact, for papers by Koichiro Mihara Breakdown of academic impact, for papers by Alessandra Tessitore Breakdown of academic impact, for papers by Mathias H. Konstandin Breakdown of academic impact, for papers by Antonella Naldini Breakdown of academic impact, for papers by Junichiro Futami Breakdown of academic impact, for papers by Jonathan I. Wilde Breakdown of academic impact, for papers by Wei Sheng Breakdown of academic impact, for papers by Takako Hirata Breakdown of academic impact, for papers by Can G. Pham
Rankless by CCL
2026